Cleveland BioLabs Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
8,488.00
3,701.90
2,708.20
3,518.40
1,948.40
1,138.20
SG&A Expense
30,587.40
17,249.70
13,359.10
9,810.80
7,528.10
5,919.90
EBIT
22,570.60
14,388.80
11,851.90
6,355.90
5,600.80
4,799.90
Unusual Expense
2,358.20
2,629.20
221.90
3,099.50
4,426.10
962.80
Non Operating Income/Expense
-
13,170.10
509.50
402.70
13.50
3.50
Interest Expense
134.20
1,089.60
99.50
-
-
-
Pretax Income
20,129.30
35.40
13,044.90
2,590.10
9,842.70
3,707.40
Consolidated Net Income
20,129.30
35.40
13,044.90
2,590.10
9,842.70
3,707.40
Net Income
17,262.90
1,629.10
12,637.60
2,658.90
9,706.50
3,612
Net Income After Extraordinaries
17,262.90
1,629.10
12,637.60
2,658.90
9,706.50
3,612
Net Income Available to Common
17,262.90
1,629.10
12,637.60
2,658.90
9,706.50
3,612
EPS (Basic)
7.67
0.60
1.79
0.24
0.87
0.32
Basic Shares Outstanding
2,250.10
2,702.90
7,060.40
10,987.20
11,192.40
11,293.80
EPS (Diluted)
7.67
0.60
1.79
0.24
0.87
0.32
Diluted Shares Outstanding
2,250.10
2,702.90
7,060.40
10,987.20
11,192.40
11,293.80
EBITDA
22,099.40
13,547.80
11,711.70
6,292.40
5,579.70
4,781.70
Other Operating Expense
-
-
1,060.80
-
-
-
Non-Operating Interest Income
-
-
-
263.70
197.80
126.10
Minority Interest Expense
2,866.40
1,593.70
407.30
68.80
136.20
95.50
Equity in Affiliates (Pretax)
217.30
285.50
362.10
-
-
-
About Cleveland BioLabs
View Profile
